Noticias

Preprint of Data from 1st 100 Participants in IRB-waived Research Study of Tollovid + Long COVID

Preprint of Data from 1st 100 Participants in I...

New York, NY, and Tel Aviv, ISRAEL, Aug. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its...

Preprint of Data from 1st 100 Participants in I...

New York, NY, and Tel Aviv, ISRAEL, Aug. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its...

Todos Medical Completes Trial Design for Tollovid™ Long COVID Clinical Study

Todos Medical Completes Trial Design for Tollov...

3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens Finalizing contracts with two Long COVID clinics to recruit patients Institutional Review Board (IRB) protocol submission imminent New York,...

Todos Medical Completes Trial Design for Tollov...

3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens Finalizing contracts with two Long COVID clinics to recruit patients Institutional Review Board (IRB) protocol submission imminent New York,...

Todos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune Diagnostics

Todos Medical Announces First Long COVID Clinic...

RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and Tel Aviv, ISRAEL, Aug....

Todos Medical Announces First Long COVID Clinic...

RTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and Tel Aviv, ISRAEL, Aug....

Todos Medical & The Alchemist’s Kitchen to Host “Long COVID: An Integrated Approach” Event Benefitting Survivor Corps

Todos Medical & The Alchemist’s Kitchen to Host...

New York, NY, and Tel Aviv, ISRAEL, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with...

Todos Medical & The Alchemist’s Kitchen to Host...

New York, NY, and Tel Aviv, ISRAEL, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, together with...

IRB-Waived Tollovid® Research Data in Acute & Long COVID

Datos preliminares del estudio de investigación...

Todos Medical, Ltd. (OTCQB: TOMDF), una empresa integral de diagnóstico médico y soluciones relacionadas, anunció hoy los datos preliminares de su empresa conjunta de propiedad mayoritaria 3CL Pharma Ltd. estudio...

Datos preliminares del estudio de investigación...

Todos Medical, Ltd. (OTCQB: TOMDF), una empresa integral de diagnóstico médico y soluciones relacionadas, anunció hoy los datos preliminares de su empresa conjunta de propiedad mayoritaria 3CL Pharma Ltd. estudio...

Protect Your House: Tollovid® is Informed Sport Certified

¡Tollovid ahora está certificado como deporte i...

Todos Medical, Ltd. (OTCQB: TOMDF), una empresa integral de diagnóstico médico y soluciones relacionadas, anunció hoy que su subsidiaria de propiedad mayoritaria 3CL Pharma, Ltd. recibió la certificación de deporte...

¡Tollovid ahora está certificado como deporte i...

Todos Medical, Ltd. (OTCQB: TOMDF), una empresa integral de diagnóstico médico y soluciones relacionadas, anunció hoy que su subsidiaria de propiedad mayoritaria 3CL Pharma, Ltd. recibió la certificación de deporte...

Tollovid – Maximum Strength 3CL Protease Inhibitor - Tollovid

Tollovid

Tollovid®

$149.50 USD
$149.50 USD
Rebaja Vendido
Envío calculado al finalizar la compra.
Ver detalles completos